BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25527419)

  • 1. Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.
    Aziz F; Yang X; Wang X; Yan Q
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1221-35. PubMed ID: 25527419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of anti-LeY antibody in the downregulation of MAPKs/COX-2 pathway in gastric cancer.
    Aziz F; Qiu Y
    Curr Drug Targets; 2014 Apr; 15(4):469-76. PubMed ID: 24533777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer.
    Aziz F; Gao W; Yan Q
    Pathol Oncol Res; 2017 Jan; 23(1):173-179. PubMed ID: 27757838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
    Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
    Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.
    Zhang LJ; Wang SY; Huo XH; Zhu ZL; Chu JK; Ma JC; Cui DS; Gu P; Zhao ZR; Wang MW; Yu J
    World J Gastroenterol; 2009 Jun; 15(22):2731-8. PubMed ID: 19522023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib inhibits Helicobacter pylori-induced invasion of gastric cancer cells through an adenine nucleotide translocator-dependent mechanism.
    Lan C; Yang L; Fan L; Zhang Y; Wang J; Guo GJ; Wan S; Yang S; Wang R; Fang D
    Anticancer Agents Med Chem; 2013 Oct; 13(8):1267-72. PubMed ID: 23574384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib inhibits CD133-positive cell migration via reduction of CCR2 in Helicobacter pylori-infected Mongolian gerbils.
    Futagami S; Hamamoto T; Shimpuku M; Nagoya H; Kawagoe T; Horie A; Shindo T; Gudis K; Sakamoto C
    Digestion; 2010; 81(3):193-203. PubMed ID: 20090335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partners in crime: The Lewis Y antigen and fucosyltransferase IV in Helicobacter pylori-induced gastric cancer.
    Aziz F; Khan I; Shukla S; Dey DK; Yan Q; Chakraborty A; Yoshitomi H; Hwang SK; Sonwal S; Lee H; Haldorai Y; Xiao J; Huh YS; Bajpai VK; Han YK
    Pharmacol Ther; 2022 Apr; 232():107994. PubMed ID: 34571111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
    Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib inhibits apurinic/apyrimidinic endonuclease-1 expression and prevents gastric cancer in Helicobacter pylori-infected mongolian gerbils.
    Futagami S; Kawagoe T; Horie A; Shindo T; Hamamoto T; Suzuki K; Kusunoki M; Miyake K; Gudis K; Tsukui T; Crowe SE; Sakamoto C
    Digestion; 2008; 78(2-3):93-102. PubMed ID: 18987470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of MUC5AC production and deposition of LEWIS determinants by HELICOBACTER PYLORI facilitate gastric tissue colonization and the maintenance of infection.
    Gonciarz W; Walencka M; Moran AP; Hinc K; Obuchowski M; Chmiela M
    J Biomed Sci; 2019 Mar; 26(1):23. PubMed ID: 30841890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
    Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
    Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
    Zhang Y; Pan KF; Zhang L; Ma JL; Zhou T; Li JY; Shen L; You WC
    Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.
    Kim N; Kim CH; Ahn DW; Lee KS; Cho SJ; Park JH; Lee MK; Kim JS; Jung HC; Song IS
    J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer.
    Liu N; Zhou N; Chai N; Liu X; Jiang H; Wu Q; Li Q
    BMC Cancer; 2016 May; 16():321. PubMed ID: 27198692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Jianpi jiedu recipe inhibited Helicobacter pylori-induced the expression of cyclooxygenase-2 via p38MAPK/ATF-2 signal transduction pathway in human gastric cancer cells].
    Liu NN; Wang Y; Wu Q
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jul; 31(7):926-31. PubMed ID: 21866663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Helicobacter pylori infection on Barrett's esophagus and esophageal adenocarcinoma formation in a rat model of chronic gastroesophageal reflux.
    Liu FX; Wang WH; Wang J; Li J; Gao PP
    Helicobacter; 2011 Feb; 16(1):66-77. PubMed ID: 21241415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication.
    Yang HB; Cheng HC; Sheu BS; Hung KH; Liou MF; Wu JJ
    Aliment Pharmacol Ther; 2007 Feb; 25(4):455-61. PubMed ID: 17270001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
    Hung KH; Yang HB; Cheng HC; Wu JJ; Sheu BS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):48-53. PubMed ID: 19793174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.